Maria Sklodowska-curie National Research Institute Of Oncology

This study is testing if a drug called empagliflozin can protect the heart from damage caused by powerful chemotherapy drugs (anthracyclines). It involves 220 cancer patients with healthy hearts who are scheduled for high-dose chemotherapy. Half will receive empagliflozin and hal…

This study aims to find out if using special surgical glues (sealants) is better than using no glue at all for preventing dangerous spinal fluid leaks after certain brain surgeries performed through the nose. Researchers will randomly assign 225 adult patients having this type of…